ALBI and PALBI Scores and HCC Prognosis | Clinical Trial | StuddyBuddy@endsection ALBI and PALBI Scores and HCC Prognosis
Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Completed NCT05720195

ALBI and PALBI Scores and HCC Prognosis

Conditions: Hepatocellular Carcinoma (HCC) Prognosis

Sex: All
Ages: 18 Years – 99 Years
Enrollment: 645
Sponsor: Sohag University

Location: Egypt

Summary

To compare the predictive ability of ALBI and PALBI grades with CTP and MELD scores.To investigate the efficacy of ALBI and PALBI grades for predicting the prognosis of HCC and overall survival among different modalities of treatment.

Eligibility Criteria

Inclusion Criteria:• The diagnosis of HCC will be based on the presence of an arterial hypervascular focal lesion > 2 cm with rapid wash-out with a single imaging modality (triphasic computed tomography (CT), or dynamic magnetic resonance imaging (MRI)) or two imaging modalities demonstrating the before mentioned feature for lesions < 2 cm with or without elevated serum alpha-fetoprotein (AFP) levels.Exclusion Criteria:Patients below 18 years old.Patients with pre-existing other malignancies.Patients with pre-existing gall bladder stones, benign strictures, or other biliary diseases.Patients with pre-existing haematologic disorders.Patients with proteinuria.Missed follow-up.

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT05720195). StuddyBuddy aggregates publicly available trial information.